CalciMedica Inc Share Price Today: Live Updates & Key Insights

CalciMedica Inc share price today is $0.609, up -21.68%. The stock opened at $0.701 against the previous close of $0.7375, with an intraday high of $0.7035 and low of $0.66765.

CalciMedica Inc Share Price Chart

CalciMedica Inc

us-stock
To Invest in {{usstockname}}
us-stock

CalciMedica Inc Share Price Performance

$0.609 -0.2168(-21.68%) CALC at 23 Mar 2026 12:22 PM Biotechnology
Lowest Today 0.66765
Highest Today 0.7035
Today’s Open 0.701
Prev. Close 0.7375
52 Week High 7.20
52 Week Low 0.46
Day’s Range: Low 0.66765 High 0.7035
52-Week Range: Low 0.46 High 7.20
1 day return -
1 Week return -26.08
1 month return +20.52
3 month return -89.27
6 month return -78.07
1 year return -66.12
3 year return -88.61
5 year return -
10 year return -

CalciMedica Inc Institutional Holdings

CalciMedica Inc Market Status

Strong Buy: 3

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

CalciMedica Inc Fundamentals

Market Cap 9.09 M

PB Ratio 7.1254

PE Ratio 0.0

Enterprise Value 8.30 M

Total Assets 13.59 M

Volume 393818

CalciMedica Inc Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-56575000 -56.6M, FY22:-35605000 -35.6M, FY21:-35821000 -35.8M, FY20:-27531000 -27.5M, FY19:-37037000 -37.0M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:null 0.0M, Q2/2025:null 0.0M, Q1/2025:-15000 -0.0M, Q3/2024:null 0.0M, Q2/2024:-15000 -0.0M

Quarterly Net worth Q3/2025:-7804000 -7.8M, Q2/2025:-5956000 -6.0M, Q1/2025:-5042000 -5.0M, Q3/2024:-5618000 -5.6M, Q2/2024:-3954000 -4.0M

About CalciMedica Inc & investment objective

Company Information CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. The company also develops Auxora for the treatment of ulcerative colitis, traumatic brain injury, and allergic asthma; and oral CRAC channel inhibitors for use in chronic inflammatory and immunologic disease. The company is based in La Jolla, California.

Organisation Biotechnology

Employees 16

Industry Biotechnology

CEO Dr. A. Rachel Leheny Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

CalciMedica Inc FAQs

What is the share price of CalciMedica Inc today?

The current share price of CalciMedica Inc is $0.609.

Can I buy CalciMedica Inc shares in India?

Yes, Indian investors can buy CalciMedica Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy CalciMedica Inc shares in India?

You can easily invest in CalciMedica Inc shares from India by:

Can I buy fractional shares of CalciMedica Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of CalciMedica Inc?

CalciMedica Inc has a market cap of $9.09 M.

In which sector does CalciMedica Inc belong?

CalciMedica Inc operates in the Biotechnology sector.

What documents are required to invest in CalciMedica Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of CalciMedica Inc?

The PE ratio of CalciMedica Inc is N/A and the PB ratio is 7.13.